Atlas Trials

Study to Determine Absorption, Metabolism, and Excretion of [14C]-SAR439859, and to Assess Absolute Oral Bioavailability of Amcenestrant (SAR439859), in Healthy Post-menopausal Women

Clinical trial NCT04940026 · COMPLETED

Trial details

NCT number
NCT04940026
Sponsor
Sanofi
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Breast CancerHealthy Volunteers
Start date
2021-06-15
Primary completion
2021-08-19
Enrollment
6

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.